Table 1.

CSI Versus Subcutaneous Injection for Treatment With FL Alone or in Combination With G-CSF (7-day counts)

CarrierFL (100 μg/kg/d)G-CSF (100 μg/kg/d)FL + G-CSF
INJCSIINJCSIINJCSIINJCSI
WBC (× 106/mL) 6.4 ± 1.7 
Neutrophils (× 106/mL)  
GM-CGC/mL blood  
 
0.61 ± 0.1 
159 ± 63.6 8.6 ± 0.5* 
 
0.79 ± 0.1* 
155 ± 41.5 7.9 ± 1.8 
 
0.60 ± 0.60 
262 ± 90.7 8.3 ± 0.9 
 
0.82 ± 0.25 
360 ± 193 10.3 ± 2.8 
 
2.04 ± 1.1 
2,620 ± 1,324 30.3 ± 5.6* 
 
19.0 ± 4.4* 
21,645 ± 3,339* 10.14 ± 0.8 
 
2.6 ± 0.56 
3,308 ± 1,358 78.7 ± 7.5* 
 
59.1 ± 6.1* 
111,132 ± 30,759* 
CarrierFL (100 μg/kg/d)G-CSF (100 μg/kg/d)FL + G-CSF
INJCSIINJCSIINJCSIINJCSI
WBC (× 106/mL) 6.4 ± 1.7 
Neutrophils (× 106/mL)  
GM-CGC/mL blood  
 
0.61 ± 0.1 
159 ± 63.6 8.6 ± 0.5* 
 
0.79 ± 0.1* 
155 ± 41.5 7.9 ± 1.8 
 
0.60 ± 0.60 
262 ± 90.7 8.3 ± 0.9 
 
0.82 ± 0.25 
360 ± 193 10.3 ± 2.8 
 
2.04 ± 1.1 
2,620 ± 1,324 30.3 ± 5.6* 
 
19.0 ± 4.4* 
21,645 ± 3,339* 10.14 ± 0.8 
 
2.6 ± 0.56 
3,308 ± 1,358 78.7 ± 7.5* 
 
59.1 ± 6.1* 
111,132 ± 30,759* 

Data presented are the mean of 2 experiments ± 1 SD, each from 5 donors.

Abbreviations: INJ, injection; CSI, continuous subcutaneous infusion.

*

P < .005; INJ v CSI.

Close Modal

or Create an Account

Close Modal
Close Modal